Kebayaone P. Gare
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kebayaone P. Gare has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Charles Muyela
Affiliations Department of family Medicine & Public Health, University of Botswana, Gaborone, Botswana, Ministry of Health and Wellness, Gaborone, Botswana
1 shared publicationDineo Kebadiretse
Affiliations Department of family Medicine & Public Health, University of Botswana, Gaborone, Botswana, Ministry of Health and Wellness, Gaborone, Botswana
1 shared publicationJohn T. Tlhakanelo
Affiliation Department of Family Medicine & Public Health, Faculty of Medicine, University of Botswana, Gaborone, Botswana
1 shared publicationKeatlaretse Siamisang
Affiliation Department of Public Health, Ministry of Health, Gaborone, Botswana
1 shared publication- Keatlaretse Siamisang
Department of Family Medicine and Public Health, University of Botswana, Gaborone, Botswana
1 shared publication Keemenao Ramogalana
Affiliation Department of Public Health, Ministry of Health, Gaborone, Botswana
1 shared publication
Latest Publications
- Open Access
- 24 February 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (2) , e0003899
The Impact of integrated management of childhood illness training on knowledge levels of healthcare workers in Botswana
The Integrated Management of Childhood Illness (IMCI) strategy was developed to improve outcomes through integration of preventive and curative interventions in countries with high mortality. This study aimed to assess the impact of IMCI training on the knowledge levels of healthcare workers (HCWs) in Botswana, comparing the trained with the non-trained. This was a cross-sectional study from a national IMCI survey across all 27-health districts of Botswana in September 2023. Within each district, random sampling was used to select 10 healthcare facilities (HCFs) to be included in the survey. HCFs were ordered by their size to ensure that all types were represented. The demographics, training and qualifications of the HCWs were documented. Stata 13.1 software was used for analysis, and data was summarized with frequencies and percentages. Pearson’s chi square test was used to compare the performances of IMCI trained versus non-IMCI trained HCWs. A p-value of <0.05 was considered statistically significant. A total of 964 HCWs participated in the survey. The most frequent cadre was General Nurse with 385 (40.7%) participants. Participants trained in IMCI were 471 (49.2%) and those who consult sick children were 615 (65.1%). Those who were IMCI trained had good (80–100%) and moderate (60–79%) knowledge levels at 51 (14.1%) and 91 (25.2%) participants respectively than those who had no IMCI training at 25 (9.9%) for good and 52 (20.6%) for moderate performances. HCWs who were not IMCI trained had poor performance (0-59%) at 175 (69.4%) participants while the IMCI trained had poor performance at 219 (60.7%). The performances showed no statistically significant difference (p = 0.092), reflective of similar knowledge levels. Overall, the performance of IMCI trained HCWs was not significantly different from those not IMCI trained, translating to that IMCI training does not have effect on knowledge levels of HCWs in management of childhood illness. This, however, should be interpreted with caution since it could be due to the stated study limitations. A future IMCI study on knowledge, attitudes and practices (KAP) or a longitudinal study would be more beneficial.
- 24 February 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (2) , e0003899
Open AccessThe Impact of integrated management of childhood illness training on knowledge levels of healthcare workers in Botswana
The Integrated Management of Childhood Illness (IMCI) strategy was developed to improve outcomes through integration of preventive and curative interventions in countries with high mortality. This study aimed to assess the impact of IMCI training on the knowledge levels of healthcare workers (HCWs) in Botswana, comparing the trained with the non-trained. This was a cross-sectional study from a national IMCI survey across all 27-health districts of Botswana in September 2023. Within each district, random sampling was used to select 10 healthcare facilities (HCFs) to be included in the survey. HCFs were ordered by their size to ensure that all types were represented. The demographics, training and qualifications of the HCWs were documented. Stata 13.1 software was used for analysis, and data was summarized with frequencies and percentages. Pearson’s chi square test was used to compare the performances of IMCI trained versus non-IMCI trained HCWs. A p-value of <0.05 was considered statistically significant. A total of 964 HCWs participated in the survey. The most frequent cadre was General Nurse with 385 (40.7%) participants. Participants trained in IMCI were 471 (49.2%) and those who consult sick children were 615 (65.1%). Those who were IMCI trained had good (80–100%) and moderate (60–79%) knowledge levels at 51 (14.1%) and 91 (25.2%) participants respectively than those who had no IMCI training at 25 (9.9%) for good and 52 (20.6%) for moderate performances. HCWs who were not IMCI trained had poor performance (0-59%) at 175 (69.4%) participants while the IMCI trained had poor performance at 219 (60.7%). The performances showed no statistically significant difference (p = 0.092), reflective of similar knowledge levels. Overall, the performance of IMCI trained HCWs was not significantly different from those not IMCI trained, translating to that IMCI training does not have effect on knowledge levels of HCWs in management of childhood illness. This, however, should be interpreted with caution since it could be due to the stated study limitations. A future IMCI study on knowledge, attitudes and practices (KAP) or a longitudinal study would be more beneficial.
- Open Access
- 29 November 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-10
The health-related quality of life of drug-resistant tuberculosis patients receiving treatment in Botswana
Drug-resistant tuberculosis (DR-TB) poses a significant global health challenge and requires treatment with potentially toxic second-line anti-TB drugs. Assessing the health-related quality of life (HRQoL) of DR-TB patients is crucial, given the impact of disease and treatment on their well-being. This study aimed to evaluate HRQoL among DR-TB patients undergoing treatment in Botswana and identify predictors of variability during the treatment period. A cross-sectional study involving almost all the eligible clients in the DR-TB treatment database was conducted at four of the six DR-TB sites in Botswana. The SF-36v2-based questionnaire was administered to all patients receiving treatment between March 2022 and June 2023. Data analysis was performed with QualityMetric Inc., LLC PRO CoRE scoring software and Stata 13.1 for the HRQoL scoring and regression analyses, respectively. A score ≤ 47 on the norm-based scoring (NBS) indicated poor HRQoL. Shorter, all-oral DR-TB regimens were introduced since 2018 but Botswana had not yet fully implemented those in the years 2022/2023. Patients had to go on treatment for 18–24 months during the time of the study. Seventy-two of the 81 eligible participants were enrolled. Participants on treatment for 13–24 months exhibited better HRQoL scores (53.3 ± 8.4) than those in the initial (0–12 months, 46.9 ± 10.8) and latter phases of treatment (> 24 months, 44.3 ± 10.1) for the Physical Component Summary (PCS) even though it was not statistically significant (p = 0.0996). The mental component summary (MCS) scores were 41.6 ± 11.3, 51.6 ± 7.8, and 41.3 ± 10.7 for 0–12, 13–24, and > 24 months, respectively, with significant differences observed for the MCS (p = 0.0097). Multivariate analysis identified renal impairment as a predictor of PCS variability, while alcohol consumption, prior TB treatment, and lung cavity on chest X-ray imaging predicted MCS variability. DR-TB patients in Botswana demonstrated comparable or improved HRQoL (> 47 NBS) in their second year (13–24 months) of treatment, contrasting with poorer HRQoL scores in the initial and final years for both the PCS and MCS. The findings underscore the necessity for tailored psychosocial support, advocated for its integration into the Botswana National TB Program as a pilot initiative before widespread implementation.
- 29 November 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-10
Open AccessThe health-related quality of life of drug-resistant tuberculosis patients receiving treatment in Botswana
Drug-resistant tuberculosis (DR-TB) poses a significant global health challenge and requires treatment with potentially toxic second-line anti-TB drugs. Assessing the health-related quality of life (HRQoL) of DR-TB patients is crucial, given the impact of disease and treatment on their well-being. This study aimed to evaluate HRQoL among DR-TB patients undergoing treatment in Botswana and identify predictors of variability during the treatment period. A cross-sectional study involving almost all the eligible clients in the DR-TB treatment database was conducted at four of the six DR-TB sites in Botswana. The SF-36v2-based questionnaire was administered to all patients receiving treatment between March 2022 and June 2023. Data analysis was performed with QualityMetric Inc., LLC PRO CoRE scoring software and Stata 13.1 for the HRQoL scoring and regression analyses, respectively. A score ≤ 47 on the norm-based scoring (NBS) indicated poor HRQoL. Shorter, all-oral DR-TB regimens were introduced since 2018 but Botswana had not yet fully implemented those in the years 2022/2023. Patients had to go on treatment for 18–24 months during the time of the study. Seventy-two of the 81 eligible participants were enrolled. Participants on treatment for 13–24 months exhibited better HRQoL scores (53.3 ± 8.4) than those in the initial (0–12 months, 46.9 ± 10.8) and latter phases of treatment (> 24 months, 44.3 ± 10.1) for the Physical Component Summary (PCS) even though it was not statistically significant (p = 0.0996). The mental component summary (MCS) scores were 41.6 ± 11.3, 51.6 ± 7.8, and 41.3 ± 10.7 for 0–12, 13–24, and > 24 months, respectively, with significant differences observed for the MCS (p = 0.0097). Multivariate analysis identified renal impairment as a predictor of PCS variability, while alcohol consumption, prior TB treatment, and lung cavity on chest X-ray imaging predicted MCS variability. DR-TB patients in Botswana demonstrated comparable or improved HRQoL (> 47 NBS) in their second year (13–24 months) of treatment, contrasting with poorer HRQoL scores in the initial and final years for both the PCS and MCS. The findings underscore the necessity for tailored psychosocial support, advocated for its integration into the Botswana National TB Program as a pilot initiative before widespread implementation.
- Open Access
- 22 August 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (8) , e0273052
Prevalence and predictors of depression, anxiety and stress among frontline healthcare workers at COVID-19 isolation sites in Gaborone, Botswana
Coronavirus disease 2019 (COVID-19) has been associated with mental health outcomes and healthcare workers (HCWs) are at the highest risk. The aim of this study was to determine the prevalence and predictors of depression, anxiety and stress, among frontline HCWs at COVID-19 isolation and treatment sites in Gaborone, Botswana. This was a cross-sectional study using self-administered questionnaires at the six (6) isolation facilities. The 42-item Depression, Anxiety and Stress Scale (DASS-42) was used to assess for the outcomes. The proportions are presented with 95% confidence intervals (95% CI). Logistic regression analysis identified predictors of the outcomes. A p value of <0.05 was considered significant. A total of 447 participants with a median age of 30 years responded. Depression, anxiety and stress were detected in 94 (21.0% (95% CI 17.3–25.1%)), 126 (28.2% (CI 24.1–32.6%)) and 71 (15.9% (12.6–19.6%)) of the participants respectively. Depression was associated with smoking (AOR 2.39 (95% CI 1.23–4.67)), working at the largest COVID-19 isolation centre, Sir Ketumile Masire Teaching Hospital (SKMTH) (AOR 0.25 (95% CI 0.15–0.43)) and experience of stigma (AOR 1.68 (95% CI 1.01–2.81)). Tertiary education (AOR 1.82 (95% CI 1.07–3.07)), SKMTH (AOR 0.49 (95% CI 0.31–0.77)), household members with chronic lung or heart disease (AOR 2.05 (95% CI 1.20–3.50)) and losing relatives or friends to COVID-19 (AOR 1.72 (95% CI 1.10–2.70)) were predictors of anxiety. Finally, predictors of stress were smoking (AOR 3.20 (95% CI 1.42–7.39)), household members with chronic heart or lung disease (AOR 2.44 (95% CI 1.27–4.69)), losing relatives or friends to COVID-19 (AOR 1.90 (1.05–3.43)) and working at SKMTH (AOR 0.24 (0.12–0.49)). Depression, anxiety and stress are common among frontline HCWs working in the COVID-19 isolation sites in Gaborone. There is an urgent need to address the mental health outcomes associated with COVID-19 including addressing the risk factors identified in this study.
- 22 August 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (8) , e0273052
Open AccessPrevalence and predictors of depression, anxiety and stress among frontline healthcare workers at COVID-19 isolation sites in Gaborone, Botswana
Coronavirus disease 2019 (COVID-19) has been associated with mental health outcomes and healthcare workers (HCWs) are at the highest risk. The aim of this study was to determine the prevalence and predictors of depression, anxiety and stress, among frontline HCWs at COVID-19 isolation and treatment sites in Gaborone, Botswana. This was a cross-sectional study using self-administered questionnaires at the six (6) isolation facilities. The 42-item Depression, Anxiety and Stress Scale (DASS-42) was used to assess for the outcomes. The proportions are presented with 95% confidence intervals (95% CI). Logistic regression analysis identified predictors of the outcomes. A p value of <0.05 was considered significant. A total of 447 participants with a median age of 30 years responded. Depression, anxiety and stress were detected in 94 (21.0% (95% CI 17.3–25.1%)), 126 (28.2% (CI 24.1–32.6%)) and 71 (15.9% (12.6–19.6%)) of the participants respectively. Depression was associated with smoking (AOR 2.39 (95% CI 1.23–4.67)), working at the largest COVID-19 isolation centre, Sir Ketumile Masire Teaching Hospital (SKMTH) (AOR 0.25 (95% CI 0.15–0.43)) and experience of stigma (AOR 1.68 (95% CI 1.01–2.81)). Tertiary education (AOR 1.82 (95% CI 1.07–3.07)), SKMTH (AOR 0.49 (95% CI 0.31–0.77)), household members with chronic lung or heart disease (AOR 2.05 (95% CI 1.20–3.50)) and losing relatives or friends to COVID-19 (AOR 1.72 (95% CI 1.10–2.70)) were predictors of anxiety. Finally, predictors of stress were smoking (AOR 3.20 (95% CI 1.42–7.39)), household members with chronic heart or lung disease (AOR 2.44 (95% CI 1.27–4.69)), losing relatives or friends to COVID-19 (AOR 1.90 (1.05–3.43)) and working at SKMTH (AOR 0.24 (0.12–0.49)). Depression, anxiety and stress are common among frontline HCWs working in the COVID-19 isolation sites in Gaborone. There is an urgent need to address the mental health outcomes associated with COVID-19 including addressing the risk factors identified in this study.